Raising the compliance bar for 24/7 medical coverage.

A small biotechnology company specializing in oncology medicines, approached Promedim for help with medical monitoring of a planned Phase 3 oncology program. The company asked for Promedim’s support to address a major internal audit finding.

Emergency medical coverage for a global intensive care study.

Promedim were asked to support a sponsor investigating a new biologic molecule to be used in the intensive care setting. The sponsor had an extensive US-based medical team but needed medical back-up in the rest-of-world especially given the sites were in Australia, Asia and Europe – as well as the US.